Log on / register
Feedback | Support | My details
Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis.
Winters ZE, Leek RD, Bradburn MJ, Norbury CJ, Harris AL
Breast Cancer Res 2003, 5:R242-9
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.
Koletsa T, Kostopoulos I, Charalambous E, Christoforidou B, Nenopoulou E, Kotoula V
Neoplasia 2008 Jul, 10:687-96
[PubMed Central] [PubMed] [Related articles]

2.
Tamoxifen-stimulated growth of breast cancer due to p21 loss.
Abukhdeir AM, Vitolo MI, Argani P, De Marzo AM, Karakas B, Konishi H, Gustin JP, Lauring J, Garay JP, Pendleton C, Konishi Y, Blair BG, Brenner K, Garrett-Mayer E, Carraway H, Bachman KE, Park BH
Proc Natl Acad Sci U S A 2008 Jan 8, 105:288-93
[PubMed Central] [PubMed] [Related articles]

3.
A prognostic index for operable, node-negative breast cancer.
McCallum M, Baker C, Gillespie K, Cohen B, Stewart H, Leonard R, Cameron D, Leake R, Paxton J, Robertson A, Purdie C, Gould A, Steel M
Br J Cancer 2004 May 17, 90:1933-41
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 4 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.